中國癌癥研究雜志（簡稱CJCR），印刷版：1000-9604；網(wǎng)上版：1993-0631；網(wǎng)址：gwww.thecjcr.org，由AME出版公司（www.amepc.org）與中國抗癌協(xié)會聯(lián)合出版。它于1995年3月作為季刊出版，現(xiàn)在自2013年2月起每兩個月出版一次。中國癌癥研究雜志每兩個月出版一次英文版，是一本致力于生命科學和醫(yī)學科學的國際期刊。它發(fā)表了同行評審的基礎調查和臨床觀察，評論和簡短通信的原始文章，為最近癌癥研究的實驗和臨床進展提供了一個論壇。該期刊的索引在科學引文索引擴展（SCIE），PubMed / PubMed Central（PMC），Scopus，SciSearch，化學文摘（CA），Excerpta Medica / EMBASE，Chinainfo，CNKI，CSCI等。中國癌癥研究雜志鼓勵所有癌癥研究領域的提交。特別感興趣的主題包括但不限于癌癥預防，癌癥病因學和流行病學，分子細胞生物學，基因診斷和基因治療，腫瘤病理學，癌癥的影像診斷，外科腫瘤學，腫瘤內科，放射腫瘤學，生物治療癌癥，微創(chuàng)手術，癌癥的分子靶向治療，介入放射學，以及各種癌癥的早期檢測，診斷和治療。

Chinese Journal of Cancer Research (CJCR; Print ISSN: 1000-9604; Online ISSN:1993-0631; www.thecjcr.org) is published by AME Publishing Company (www.amepc.org) in association with Chinese Anti-Cancer Association.It was launched in March 1995 as a quarterly publication and is now published bi-monthly since February 2013.CJCR is published bi-monthly in English, and is an international journal devoted to the life sciences and medical sciences. It publishes peer-reviewed original articles of basic investigations and clinical observations, reviews and brief communications providing a forum for the recent experimental and clinical advances in cancer research. This journal is indexed in Science Citation Index Expanded (SCIE), PubMed/PubMed Central (PMC), Scopus, SciSearch, Chemistry Abstracts (CA), the Excerpta Medica/EMBASE, Chinainfo, CNKI, CSCI, etc.CJCR encourages submissions from all areas of cancer research. Topics of particular interest include, but are not limited to, cancer prevention, cancer etiology and epidemiology, molecular cell biology, gene diagnosis and gene therapy, tumor pathology, imaging diagnosis of cancer, surgical oncology, medical oncology, radiation oncology, biological therapy of cancer, minimally invasive surgery, molecular targeted therapy for cancer, interventional radiology, as well as early detection, diagnosis and treatment in various cancers.